AGRX Agile Therapeutics, Inc.Stock Price & Overview
$0.38
Charts
Quant Ranking
AGRX Analysis
AGRX News
Latest Headlines
People Also Follow
Similar to AGRX
ETFs Holding AGRX
AGRX Company Profile
Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
AGRX Revenue
AGRX Earnings Per Share
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
AGRX Ownership
AGRX Peers
Risk
Technicals
AGRX Transcripts
Investor Presentations
AGRX SEC Filings
Press Releases
AGRX Income Statement
AGRX Balance Sheet
AGRX Cash Flow Statement
AGRX Long Term Solvency
Discover More
You may be interested in: